Author | Brandon Bernard, MD, MPH

Articles

POINT-Prostate Cancer Genomic Analysis: Routine or Research Only?

December 17, 2018

In this side of the Point/Counterpoint, Drs. Bernard and Flaig state that genomic testing should be routine in the management of prostate cancer patients.

Complications of Androgen Deprivation Therapy in Men With Prostate Cancer

September 18, 2018

ByTejas Patil, MD

Brandon Bernard, MD, MPH

This article summarizes the key side effects associated with ADT for the treatment of prostate cancer and discusses strategies to optimize management.

Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification

July 15, 2018

ByTyler P. Robin, MD, PhD

Paul D. Maroni, MD

Bennett B. Chin, MD

Francisco G. La Rosa, MD

Brandon Bernard, MD, MPH

Thomas J. Pugh, MD

A 62-year-old man with prostate adenocarcinoma elected to proceed with radical prostatectomy as definitive management. After his pathology report showed stage IIIB disease, he elected for observation. What happened next?